Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Transcranial Alternating Current Stimulation (tACS) for the Treatment of Refractory Constipation Comorbid With Somatic Symptom Disorder
NCT07323407 is registered in ClinicalTrials.gov with Xijing Hospital of Digestive Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Transcranial Alternating Current Stimulation (tACS) for the Treatment of Refractory Constipation Comorbid With Somatic Symptom Disorder
- Lead sponsor
- Xijing Hospital of Digestive Diseases
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 20, 2025
- Completion date
- December 1, 2026
- Enrollment
- 60 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
functional constipation (fc), refractory constipation, somatic symptom disorder (dsm-5)